We are thrilled to announce our partnership with Creyon Bio! We look forward to combining our genetics and target biology expertise with Creyon's oligonucleotide engineering capabilities to develop novel therapeutics for neurodegenerative diseases.
Today we announced our #partnership with Cajal Neuroscience for the development of novel oligonucleotide-based medicines for neurodegenerative diseases. We look forward to working with Cajal to advance these much needed therapies. Read the full press release: https://lnkd.in/emmfeHpQ